Proof FDA is compromised; Demonizes safe and effective treatments for COVID-19
We at AFLDS have known for many months that Ivermectin is a safe and effective treatment for COVID- 19. To preempt unlawful restrictions by the medical and pharmaceutical boards as we witnessed with our endorsement of HCQ, we did not discuss it publicly. While there are more studies showing that HCQ is superior to Ivermectin in the treatment of COVID-19, it remains up to your physician to help you make the best decision. (America's Frontline Doctors)
Bret Samuel Weinstein is an American evolutionary biologist
“Ivermectin shows itself to be about 86 percent effective at preventing contraction of Covid. If you get 70 percent of the population to take the prophylaxis … that level of prophylaxis is more than sufficient by a lot to drive this to extinction.” (
And yet, ivermectin hasn’t been approved by the FDA, the World Health Organization (WHO) says it should “only be used within clinical trials,” and many other regulatory agencies say the same.
Pierre Kory is an American critical care physician who gained attention during the COVID-19 pandemic for advocating widespread off-label use of certain drugs as treatments for COVID-19. Kory testified twice at the U.S. Senate regarding COVID-19
Dr. Korey believes ivermectin is “showing really strong efficacy” in alleviating the symptoms of “long Covid” (long-term effects of the disease such as fatigue and brain fog)—the first patient he treated with long Covid symptoms was, according to Kory, “crying for joy.” He says ivermectin is anti-viral and anti-inflammatory, and that it improves “post-vaccine syndromes.” Ivermectin was slaying the Delta variant.
South Africa and Zimbabwe, especially Zimbabwe—when they were getting hurt earlier in this year—they basically eradicated Covid with widespread adoption of ivermectin. They were dealing with the South African variant.”
How about the P.1 variant in Brazil? “Totally susceptible to ivermectin,” Kory says. And the U.K. variant? Same thing, according to Kory. This is one of the best examples of something that—it’s almost too good to be true, but turns out actually to be true.”
HCQ
Hydroxychloroquine (HCQ) has shown efficacy against coronavirus disease 2019 (COVID-19) in some but not all studies. We hypothesized that a systematic review would show HCQ to be effective against COVID-19, more effective when provided earlier, not associated with worsening disease and safe. We searched PubMed, Cochrane, Embase, Google Scholar and Google for all reports on HCQ as a treatment for COVID-19 patients. This included preprints and preliminary reports on larger COVID-19 studies. We examined the studies for efficacy, time of administration and safety. HCQ was found to be consistently effective against COVID-19 when provided early in the outpatient setting. It was also found to be overall effective in inpatient studies. No unbiased study found worse outcomes with HCQ use. No mortality or serious safety adverse events were found. HCQ is consistently effective against COVID-19 when provided early in the outpatient setting, it is overall effective against COVID-19, it has not produced worsening of disease and it is safe.
FDA's recommendation
The Food and Drug Administration (FDA) has approved one drug, remdesivir (Veklury), to treat COVID-19.Mar 23, 2021
Cost comparisons
Ivermectin- $65 for 24 pills
Hydrochloroquine- (averages about $20, but as low as $6)
Veklury-$550 per injection
Is it possible money 💰 has perverted the science behind the objections to alternatives to the vaccines?
https://pubmed.ncbi.nlm.nih.gov/33042552/
https://m.goodrx.com/hydroxychloroquine
Comments
Post a Comment